久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Marksans Pharma gets EIR from US FDA for its Goa facility

expressbpdOctober 10, 2017

Tag: Marksans Pharma , Goa facility , EIR

EIR is issued to a company detailing inspectional findings

Marksans Pharma has received Establishment Inspection Report (EIR) from the US health regulator for its Goa facility.

The company has received EIR from the United States Food and Drug Administration (USFDA) after inspection of its Goa facility from April 3-7, 2017, Marksans Pharma said in a BSE filing.

As per the USFDA, after the completion of an inspection of a facility, an EIR is issued to a company detailing inspectional findings.

Previous:Vice President to inaugurate third International Conference on Yoga

Next:Lupin receives FDA approval for generic Corgard Tablets

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service